Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02430467 · ClinicalTrials.gov registry record · NA

Caregiver-Guided Pain Management Training in Palliative Care

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
452
Enrollment target

NCT02430467: Completed NA study, sponsored by Duke University.

NCT02430467 is a NA study that has completed, run by Duke University. The registered enrollment target is 452 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02430467, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
452 participants
Enrollment target

Study Summary

The purpose of this study is to develop more effective ways to help patients and their caregivers cope with cancer pain. The investigators are looking at the usefulness of a Caregiver-Guided Pain Management Training Intervention versus Pain Education.

Primary Outcome

Caregiver Self-Efficacy Scale

Interventions

  • BEHAVIORAL Caregiver-guided pain management training (CG-PMT)
  • BEHAVIORAL Enhanced treatment-as-usual (TAU)

Trial Details

FieldValue
Enrollment Target 452 participants
Start Date 2015-07
Est. Completion 2019-10-04
Phase NA
Duke University

1,725 total trials

What the finished NCT02430467 record still lists

NCT02430467 is an interventional study that assigns participants to a tested intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).

The record links to 0 conditions, and to 2 interventions - of which Caregiver-guided pain management training (CG-PMT) is the first listed.

NCT02430467 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02430467 about?

NCT02430467 is a clinical study titled "Caregiver-Guided Pain Management Training in Palliative Care". The purpose of this study is to develop more effective ways to help patients and their caregivers cope with cancer pain. The investigators are looking at the usefulness of a Caregiver-Guided Pain Management Training Intervention versus Pain Education.

What is the current status of trial NCT02430467?

This trial is currently completed. It is a NA study. The enrollment target is 452 participants. The study started on 2015-07. Estimated completion is 2019-10-04.

What interventions are being tested in trial NCT02430467?

The interventions under investigation include: Caregiver-guided pain management training (CG-PMT) (BEHAVIORAL), Enhanced treatment-as-usual (TAU) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02430467?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02430467's enrollment target sits among peer trials

452 225th of 2000 higher than 1,776 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05676255 · 452 participants · Phase 2

    The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project

  • NCT05703178 · 452 participants · Phase 3

    Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia

  • NCT03460977 · 453 participants · Phase 1

    A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

  • NCT04708171 · 453 participants

    The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02430467, the US trial registry maintained by the National Library of Medicine. NCT02430467 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.